Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Current Deferred Tax Assets (2021 - 2022)

Universe Pharmaceuticals' Current Deferred Tax Assets history spans 2 years, with the latest figure at $7.6 million for Q1 2022.

  • On a quarterly basis, Current Deferred Tax Assets changed N/A to $7.6 million in Q1 2022 year-over-year; TTM through Mar 2022 was $7.6 million, a N/A change, with the full-year FY2021 number at $7.5 million, changed N/A from a year prior.
  • Current Deferred Tax Assets hit $7.6 million in Q1 2022 for Universe Pharmaceuticals, up from $7.5 million in the prior quarter.
  • Over the last five years, Current Deferred Tax Assets for UPC hit a ceiling of $7.6 million in Q1 2022 and a floor of $7.5 million in Q3 2021.